Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Identifieur interne : 000355 ( 2020/Analysis ); précédent : 000354; suivant : 000356

Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.

Auteurs : Houman Khosravani [Canada] ; Phavalan Rajendram [Canada] ; Lowyl Notario [Canada] ; Martin G. Chapman [Canada] ; Bijoy K. Menon [Canada]

Source :

RBID : pubmed:32233980

Abstract

Background and Purpose- Hyperacute assessment and management of patients with stroke, termed code stroke, is a time-sensitive and high-stakes clinical scenario. In the context of the current Coronavirus Disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus, the ability to deliver timely and efficacious care must be balanced with the risk of infectious exposure to the clinical team. Furthermore, rapid and effective stroke care remains paramount to achieve maximal functional recovery for those needing admission and to triage care appropriately for those who may be presenting with neurological symptoms but have an alternative diagnosis. Methods- Available resources, COVID-19-specific infection prevention and control recommendations, and expert consensus were used to identify clinical screening criteria for patients and provide the required nuanced considerations for the healthcare team, thereby modifying the conventional code stroke processes to achieve a protected designation. Results- A protected code stroke algorithm was developed. Features specific to prenotification and clinical status of the patient were used to define precode screening. These include primary infectious symptoms, clinical, and examination features. A focused framework was then developed with regard to a protected code stroke. We outline the specifics of personal protective equipment use and considerations thereof including aspects of crisis resource management impacting team role designation and human performance factors during a protected code stroke. Conclusions- We introduce the concept of a protected code stroke during a pandemic, as in the case of COVID-19, and provide a framework for key considerations including screening, personal protective equipment, and crisis resource management. These considerations and suggested algorithms can be utilized and adapted for local practice.

DOI: 10.1161/STROKEAHA.120.029838
PubMed: 32233980


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:32233980

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.</title>
<author>
<name sortKey="Khosravani, Houman" sort="Khosravani, Houman" uniqKey="Khosravani H" first="Houman" last="Khosravani">Houman Khosravani</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada (H.K., P.R.).</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rajendram, Phavalan" sort="Rajendram, Phavalan" uniqKey="Rajendram P" first="Phavalan" last="Rajendram">Phavalan Rajendram</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada (H.K., P.R.).</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Notario, Lowyl" sort="Notario, Lowyl" uniqKey="Notario L" first="Lowyl" last="Notario">Lowyl Notario</name>
<affiliation wicri:level="4">
<nlm:affiliation>Sunnybrook Health Sciences Centre, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Canada (L.N.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Sunnybrook Health Sciences Centre, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chapman, Martin G" sort="Chapman, Martin G" uniqKey="Chapman M" first="Martin G" last="Chapman">Martin G. Chapman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada (M.G.C.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Menon, Bijoy K" sort="Menon, Bijoy K" uniqKey="Menon B" first="Bijoy K" last="Menon">Bijoy K. Menon</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine and the Hotchkiss Brain Institute, University of Calgary, Canada (B.K.M.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine and the Hotchkiss Brain Institute, University of Calgary</wicri:regionArea>
<placeName>
<settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32233980</idno>
<idno type="pmid">32233980</idno>
<idno type="doi">10.1161/STROKEAHA.120.029838</idno>
<idno type="wicri:Area/PubMed/Corpus">000423</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000423</idno>
<idno type="wicri:Area/PubMed/Curation">000423</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000423</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000289</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000289</idno>
<idno type="wicri:Area/Ncbi/Merge">003668</idno>
<idno type="wicri:Area/Ncbi/Curation">003668</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003668</idno>
<idno type="wicri:Area/Main/Merge">000355</idno>
<idno type="wicri:Area/Main/Curation">000355</idno>
<idno type="wicri:Area/Main/Exploration">000355</idno>
<idno type="wicri:Area/2020/Extraction">000355</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.</title>
<author>
<name sortKey="Khosravani, Houman" sort="Khosravani, Houman" uniqKey="Khosravani H" first="Houman" last="Khosravani">Houman Khosravani</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada (H.K., P.R.).</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Rajendram, Phavalan" sort="Rajendram, Phavalan" uniqKey="Rajendram P" first="Phavalan" last="Rajendram">Phavalan Rajendram</name>
<affiliation wicri:level="4">
<nlm:affiliation>From the Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Canada (H.K., P.R.).</nlm:affiliation>
<orgName type="university">Université de Toronto</orgName>
<country>Canada</country>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Notario, Lowyl" sort="Notario, Lowyl" uniqKey="Notario L" first="Lowyl" last="Notario">Lowyl Notario</name>
<affiliation wicri:level="4">
<nlm:affiliation>Sunnybrook Health Sciences Centre, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Canada (L.N.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Sunnybrook Health Sciences Centre, Lawrence S. Bloomberg Faculty of Nursing, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Chapman, Martin G" sort="Chapman, Martin G" uniqKey="Chapman M" first="Martin G" last="Chapman">Martin G. Chapman</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada (M.G.C.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Interdepartmental Division of Critical Care Medicine, University of Toronto</wicri:regionArea>
<placeName>
<settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
<orgName type="university">Université de Toronto</orgName>
</affiliation>
</author>
<author>
<name sortKey="Menon, Bijoy K" sort="Menon, Bijoy K" uniqKey="Menon B" first="Bijoy K" last="Menon">Bijoy K. Menon</name>
<affiliation wicri:level="4">
<nlm:affiliation>Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine and the Hotchkiss Brain Institute, University of Calgary, Canada (B.K.M.).</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Department of Clinical Neurosciences, Radiology, and Community Health Sciences, Cumming School of Medicine and the Hotchkiss Brain Institute, University of Calgary</wicri:regionArea>
<placeName>
<settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Stroke</title>
<idno type="eISSN">1524-4628</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background and Purpose- Hyperacute assessment and management of patients with stroke, termed code stroke, is a time-sensitive and high-stakes clinical scenario. In the context of the current Coronavirus Disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus, the ability to deliver timely and efficacious care must be balanced with the risk of infectious exposure to the clinical team. Furthermore, rapid and effective stroke care remains paramount to achieve maximal functional recovery for those needing admission and to triage care appropriately for those who may be presenting with neurological symptoms but have an alternative diagnosis. Methods- Available resources, COVID-19-specific infection prevention and control recommendations, and expert consensus were used to identify clinical screening criteria for patients and provide the required nuanced considerations for the healthcare team, thereby modifying the conventional code stroke processes to achieve a protected designation. Results- A protected code stroke algorithm was developed. Features specific to prenotification and clinical status of the patient were used to define precode screening. These include primary infectious symptoms, clinical, and examination features. A focused framework was then developed with regard to a protected code stroke. We outline the specifics of personal protective equipment use and considerations thereof including aspects of crisis resource management impacting team role designation and human performance factors during a protected code stroke. Conclusions- We introduce the concept of a protected code stroke during a pandemic, as in the case of COVID-19, and provide a framework for key considerations including screening, personal protective equipment, and crisis resource management. These considerations and suggested algorithms can be utilized and adapted for local practice.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Alberta</li>
<li>Ontario</li>
</region>
<settlement>
<li>Calgary</li>
<li>Toronto</li>
</settlement>
<orgName>
<li>Université de Calgary</li>
<li>Université de Toronto</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Ontario">
<name sortKey="Khosravani, Houman" sort="Khosravani, Houman" uniqKey="Khosravani H" first="Houman" last="Khosravani">Houman Khosravani</name>
</region>
<name sortKey="Chapman, Martin G" sort="Chapman, Martin G" uniqKey="Chapman M" first="Martin G" last="Chapman">Martin G. Chapman</name>
<name sortKey="Menon, Bijoy K" sort="Menon, Bijoy K" uniqKey="Menon B" first="Bijoy K" last="Menon">Bijoy K. Menon</name>
<name sortKey="Notario, Lowyl" sort="Notario, Lowyl" uniqKey="Notario L" first="Lowyl" last="Notario">Lowyl Notario</name>
<name sortKey="Rajendram, Phavalan" sort="Rajendram, Phavalan" uniqKey="Rajendram P" first="Phavalan" last="Rajendram">Phavalan Rajendram</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000355 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000355 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    2020
   |étape=   Analysis
   |type=    RBID
   |clé=     pubmed:32233980
   |texte=   Protected Code Stroke: Hyperacute Stroke Management During the Coronavirus Disease 2019 (COVID-19) Pandemic.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i   -Sk "pubmed:32233980" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021